Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - INTEREST INCOME & EXPENSE
Interest Income & Expense HALO - Halozyme Therapeutics, Inc.
18.1 M
LAST VALUE
3.33%
2 YEAR CAGR
9.25%
5 YEAR CAGR
12.48%
10 YEAR CAGR